이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
DexCom 대차 대조표 상태
재무 상태 기준 확인 6/6
DexCom 의 총 주주 지분은 $2.2B 이고 총 부채는 $2.4B, 이는 부채 대 자기자본 비율을 108.4% 로 가져옵니다. 총자산과 총부채는 각각 $6.5B 및 $4.2B 입니다. DexCom 의 EBIT는 $651.6M 이며 이자보상배율은 -5.1 입니다. $2.9B 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
108.4%
부채 비율
US$2.44b
부채
| 이자 보상 비율 | -5.1x |
| 현금 | US$2.90b |
| 주식 | US$2.25b |
| 총 부채 | US$4.24b |
| 총 자산 | US$6.48b |
최근 재무 상태 업데이트
DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly
Jun 28
Is DexCom (NASDAQ:DXCM) Using Too Much Debt?
Mar 29DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly
Dec 18DexCom (NASDAQ:DXCM) Could Easily Take On More Debt
Sep 13DexCom (NASDAQ:DXCM) Has A Rock Solid Balance Sheet
Jun 05These 4 Measures Indicate That DexCom (NASDAQ:DXCM) Is Using Debt Safely
Mar 03Recent updates
DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly
Jun 28Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)
Jun 03Dexcom: Positive Catalysts Ahead To Support Growth
May 13If EPS Growth Is Important To You, DexCom (NASDAQ:DXCM) Presents An Opportunity
May 07DexCom: Attractive Discount After Strong Earnings Results
May 06Returns At DexCom (NASDAQ:DXCM) Are On The Way Up
Apr 25Why We're Not Concerned About DexCom, Inc.'s (NASDAQ:DXCM) Share Price
Apr 12DexCom Is Pricey For A Reason - Its Growth Story Reflects That
Apr 11Is DexCom (NASDAQ:DXCM) Using Too Much Debt?
Mar 29Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?
Mar 04DexCom: A Wealth Compounder In Healthcare
Feb 14DexCom: Stelo Stellar Outlook
Jan 17DexCom (NASDAQ:DXCM) Is Experiencing Growth In Returns On Capital
Jan 15DexCom, Inc. (NASDAQ:DXCM) Not Lagging Industry On Growth Or Pricing
Jan 01DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly
Dec 18A Look At The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)
Dec 05At US$109, Is It Time To Put DexCom, Inc. (NASDAQ:DXCM) On Your Watch List?
Nov 21DexCom (NASDAQ:DXCM) Is Looking To Continue Growing Its Returns On Capital
Sep 28DexCom (NASDAQ:DXCM) Could Easily Take On More Debt
Sep 13Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)
Aug 29Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?
Aug 14DexCom (NASDAQ:DXCM) Has A Rock Solid Balance Sheet
Jun 05There's Been No Shortage Of Growth Recently For DexCom's (NASDAQ:DXCM) Returns On Capital
May 16Do DexCom's (NASDAQ:DXCM) Earnings Warrant Your Attention?
Mar 21These 4 Measures Indicate That DexCom (NASDAQ:DXCM) Is Using Debt Safely
Mar 03DexCom (NASDAQ:DXCM) Is Doing The Right Things To Multiply Its Share Price
Feb 13DexCom (NASDAQ:DXCM) Seems To Use Debt Quite Sensibly
Nov 25Returns Are Gaining Momentum At DexCom (NASDAQ:DXCM)
Oct 21Dexcom launches G7 glucose monitoring system in parts of Europe, Asia
Oct 04What Is DexCom, Inc.'s (NASDAQ:DXCM) Share Price Doing?
Sep 24DexCom: A High-Priced Medical Devices Company Remains Stuck In A Downtrend
Sep 21DexCom promotes technology chief Leach to COO
Aug 31DexCom (NASDAQ:DXCM) Has A Pretty Healthy Balance Sheet
Aug 01DexCom stock down ~7% after hours as Q2 results miss expectations
Jul 28Estimating The Intrinsic Value Of DexCom, Inc. (NASDAQ:DXCM)
Jul 13재무 상태 분석
단기부채: DXCM 의 단기 자산 ( $4.6B )이 단기 부채( $1.6B ).
장기 부채: DXCM 의 단기 자산( $4.6B )이 장기 부채( $2.6B ).
부채 대 자본 내역 및 분석
부채 수준: DXCM 총 부채보다 더 많은 현금을 보유하고 있습니다.
부채 감소: DXCM 의 부채 대 자기자본 비율은 지난 5년간 152.9% 에서 108.4% 로 감소했습니다.
부채 범위: DXCM 의 부채는 영업 현금 흐름 ( 32.9% )에 의해 잘 충당되었습니다.
이자 보장: DXCM 지불하는 것보다 더 많은 이자를 벌기 때문에 이자 지불 보장은 문제가 되지 않습니다.